RARE

ULTRAGENYX PHARMACEUTICAL INC

Healthcare | Mid Cap

-$1.40

EPS Forecast

$139.1

Revenue Forecast

The company already released most recent quarter's earnings. We will publish our AI's next quarter's forecast around 2024-12-31
ALKSAlkermes PlcBMRNBiomarin Pharmaceutical IncSAGESage Therapeutics IncALNYAlnylam Pharmaceuticals IncIONSIonis Pharmaceuticals IncJAZZJazz Pharmaceuticals PlcPAHCPhibro Animal Health CorpSRPTSarepta Therapeutics IncNKTRNektar Therapeutics